Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder

Neurochemical Research

Volumn 37, Issue 2, 2012, Pages 330-334

  Archana, E ^a   Pai, Priya ^a   Prabhu, Bhavya K ^a   Shenoy, Revathi P ^a   Prabhu, Krishnananda ^a   Rao, Anjali ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

ADHD; Ceruloplasmin; Magnesium; Protein thiols; Pseudocholinesterase; Saliva

Indexed keywords

CERULOPLASMIN; CHOLINESTERASE; MAGNESIUM; THIOL;

ARTICLE; ATTENTION DEFICIT DISORDER; CHEMICAL PARAMETERS; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOWN REGULATION; FEMALE; FLOW MEASUREMENT; FLOW RATE; HUMAN; MALE; PH; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SALIVA ANALYSIS; SALIVA LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; UPREGULATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CERULOPLASMIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNESIUM; MALE; ROC CURVE; SALIVA;

EID: 84856393876     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0616-x     Document Type: Article

References (34)

1. Jensen PS (1999) Fact versus fancy concerning the multimodal treatment study for attention-deficit hyperactivity disorder. Can J Psychiatry 44:975-980 (Pubitemid 30062396)
2. Zwi M, Ramchandani P, Joughin C (2000) Evidence and belief in ADHD. BMJ 321:975-976
3. Szymanski ML, Zolotor A (2001) Attention-deficit/hyperactivity disorder: management. Am Fam Phys 64:1355-1362 (Pubitemid 32983372)
4. Levy F (2002) A symposium on attention-deficit hyperactivity disorder (ADHD). Developments in treatment. Aust N Z J Psychiatry 31:477-479 (Pubitemid 34982121)
5. Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A (2006) Clinical review: evidence-based diagnosis and treatment of ADHD in children. Mo Med 103:617-621
6. Bhatia MS, Nigam VR, Bohra N, Malik SC (1991) Attention deficit disorder with hyperactivity among pediatric outpatients. J Child Psychol Psychiatry 32:297-306
7. Ullebø AK, Posserud MB, Heiervang E, Obel C, Gillberg C (2011) Prevalence of the ADHD phenotype in 7- to 9-year-old children: effects of informant, gender and non-participation. Soc Psychiatry Psychiatr Epidemiol. doi: 10.1007/s00127-011-0379-3
8. Safren SA (2006) Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 67(Suppl 8):46-50 (Pubitemid 44385606)
9. Malhi P, Singhi P (2000) Spectrum of attention deficit hyperactivity disorders in children among referrals to psychology services. Indian Pediatr 37:1256-1260
10. Brunsvold GL, Oepen G, Federman EJ, Akins R (2008) Comorbid depression and ADHD in children and adolescents. Psychiatric Times 25:1-2
11. Pineda DA, Palacio LG, Puerta IC, Merchán V, Arango CP, Galvis AY, Gómez M, Aguirre DC, Lopera F, Arcos-Burgos M (2007) Enviromental influences that affect attention deficit/hyperactivity disorder: study of a genetic isolate. Eur Child Adolesc Psychiatry 16:337-346 (Pubitemid 47305459)
12. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP (2006) Exposure to environmental toxicants and attention deficit hyperactivity disorder in US children. Environ Health Perspect 114:1904-1909 (Pubitemid 44873693)
13. Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E (2009) Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep 61:436-447
14. Tsaluchidu S, Cocchi M, Tonello L, Puri BK (2008) Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 8(Suppl 1):S5 (Pubitemid 351964890)
15. Paul A, Motchnik A, Bruce NA (1994) Measurement of antioxidants in human blood plasma. Methods Enzymol 234:269-278
16. Thomas JA, Chai YC, Jung CH (1994) Protein S-thiolation and dethilolation. Methods Enzymol 233:385-395
17. Hu M (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:381-385
18. Texel SJ, Xu X, Harris ZL (2008) Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans 36:1277-1278
19. Meletis CD, Zabriskie N (2008) Attention-deficit hyperactivity disorder. Altern Complement Therap 14:235-242
20. Starobrat-Hermelin B (1998) The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders. Ann Acad Med Stetin 44:297-314
21. Niederhofer H (2005) Serum cholinesterase levels elevated in patients suffering from ADHD. J Atten Disord 9:382-383 (Pubitemid 41608109)
22. Motchnik AP, Frei B, Ames NB (1994) Measurement of antioxidants in human blood plasma: protein thiols. In: Packer L (eds) Oxygen radicals in biological systems; methods in enzymology. vol 234, part D. Academic Press, California, pp 273-274
23. Ravin HA (1961) An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 58:161-168
24. Bergmeyer HU (1984) Cholinesterase. Methods of enzymatic analysis, volume IV, enzyme 2: esterase, glycosidase, lyase, ligase, 3rd edn. Verlag Chemie GmbH, D-6944 Wienheim. Deerfield Beach, Florida, pp 63-74
25. Texel SJ, Xu X, Harris ZL (2008) Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans 36(Pt 6):1277-1281
26. Nizankowska BT, Korczowski R, Zys K, Rybak A (1993) Level of magnesium in blood serum in children from the province of Rzesz'ow. Wiad Lek (Poland) 46:120-122
27. 6: I. Attention deficit hyperactivity disorders. Magnes Res 19:46-52 (Pubitemid 43945610)
28. Nogovitsina OR, Livitina EV (2006) Effect of MAGNE-B6 on the clinical and biochemical manifestations of the syndrome of attention deficit and hyperactivity in children. Eksp Klin Farmakol 69:74-77 (Pubitemid 43891540)
29. Curtis LT, Patel K (2008) Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med 14:79-85 (Pubitemid 351185434)
30. Schmidt ME, Kruesi MJ, Elia J, Borcherding BG, Elin RJ, Hosseini JM, McFarlin KE, Hamburger S (1994) Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys. Psychiatry Res 54:199-210
31. Laires MJ, Monteiro CP, Bicho M (2004) Role of cellular magnesium in health and human disease. Frontiers Biosci 9:262-276 (Pubitemid 38925458)
32. Kozielec T, Starobrat-Hermelin B (1997) Assessment of magnesium levels in children with attention deficient hyperactivity disorder (ADHD). Magnes Res 10:149-156
33. Kloszewska I (2002) Acetylcholinesterase inhibitors-beyond Alzheimer's disease. Psychiatr Pol 36:133-141
34. Aldridge WN (1952) The differentiation of true and pseudocholinesterase using organo-phosphorus compounds, vol 52. Medical Research Council Unit for Research in Toxicology, Serum Institute, Carshalton, Surrey pp 63-67